Jim Darrow

Title: Jim Darrow: Innovator in CNS and Peripheral Disorder Treatments

Introduction

Jim Darrow is a notable inventor based in Wallingford, CT (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target central nervous system (CNS) and peripheral disorders. His innovative work has the potential to impact the treatment of various mental health and physiological conditions.

Latest Patents

Darrow holds a patent for 5-substituted-2-arylpyrazines. This patent encompasses novel compounds that act as selective modulators of corticotropin-releasing factor (CRF) receptors. The compounds are particularly useful in treating stress, anxiety, depression, cardiovascular disorders, and eating disorders. The patent also details methods of treatment and packaged pharmaceutical compositions that utilize these compounds. Additionally, the compounds serve as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding.

Career Highlights

Throughout his career, Jim Darrow has been associated with Neurogen Corporation, where he has focused on the development of innovative therapeutic solutions. His work has contributed to advancing the understanding and treatment of various disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Darrow has collaborated with notable colleagues, including Taeyoung Yoon and Ping Ge. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Jim Darrow's contributions to the field of pharmacology through his innovative patents and collaborations highlight his role as a key inventor in the treatment of CNS and peripheral disorders. His work continues to pave the way for advancements in medical science.